DSP MF sells 29 lakh shares of Cohance Lifesciences, stake falls to 3.53%

Fii Holding DeclinedOwnership Changes View source PDF Explain this filing

COHANCE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.2%Reaction day

₹464.20

prior close

₹451.65

announcement price

In-mkt

timing

Nifty Smallcap 250market-0.3%-3.9% vs market

Pharmaceuticals peers, median of 165sector-0.6%-3.6% vs sector

On the reaction day the stock moved 3.9 pts less than Nifty Smallcap 250 and 3.6 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.3

15m

-0.3

30m

-0.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.2-0.3-3.9-0.6-3.6

Next day

-4.4-0.1-4.3-0.3-4.1

-4.8-0.6-4.2-0.6-4.2

-3.7-0.4-3.3-1.4-2.3

-2.0-0.2-1.9-1.1-1.0

-4.1-0.8-3.3-1.9-2.2

-0.4+0.2-0.6-1.4+1.0

15d

-1.0-0.7-0.3-0.9-0.1

-8.5-2.7-5.8-0.2-8.3

-4.0-3.3-0.7-3.2-0.8

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

DSP Trustee, acting for DSP Mutual Fund schemes, sold 28,99,996 shares (around 0.76% stake) of Cohance Lifesciences via the open market on August 7, 2026. Holding dropped from 4.29% (1.63 crore shares) to 3.53% (1.34 crore shares). The acquirer is not a promoter. Filing made under SEBI SAST Regulation 29(2) since the change exceeds 2% versus the earlier disclosure.

Likely market impact

Reduced MF holding may signal profit booking or portfolio rebalancing by DSP funds; stake still meaningful at 3.53% and not a promoter exit.